Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer.

× No keyword cloud information.

47 in total

Review 1. Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?

Authors: Fengzhi Li; Tao Jiang; Qingyong Li; Xiang Ling
Journal: Am J Cancer Res Date: 2017-12-01 Impact factor: 6.166

Review 2. Putative effects of potentially anti-angiogenic drugs in rheumatic diseases.

Authors: Nicola Maruotti; Francesco Paolo Cantatore; Domenico Ribatti
Journal: Eur J Clin Pharmacol Date: 2013-11-07 Impact factor: 2.953

Review 3. Topoisomerases as anticancer targets.

Authors: Justine L Delgado; Chao-Ming Hsieh; Nei-Li Chan; Hiroshi Hiasa
Journal: Biochem J Date: 2018-01-23 Impact factor: 3.857

4. Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo.

Authors: T Tsuruo; T Matsuzaki; M Matsushita; H Saito; T Yokokura
Journal: Cancer Chemother Pharmacol Date: 1988 Impact factor: 3.333

5. Potent antiviral activity of topoisomerase I and II inhibitors against Kaposi's sarcoma-associated herpesvirus.

Authors: Lorenzo González-Molleda; Yan Wang; Yan Yuan
Journal: Antimicrob Agents Chemother Date: 2011-11-21 Impact factor: 5.191

6. Pharmacokinetics and pharmacodynamics of topotecan administered daily for 5 days every 3 weeks.

Authors: L J van Warmerdam; J Verweij; J H Schellens; H Rosing; B E Davies; M de Boer-Dennert; R A Maes; J H Beijnen
Journal: Cancer Chemother Pharmacol Date: 1995 Impact factor: 3.333

7. Comparative Metabolism of Batracylin (NSC 320846) and N-acetylbatracylin (NSC 611001) Using Human, Dog, and Rat Preparations In Vitro.

Authors: Joseph M Covey; Joel M Reid; Sarah A Buhrow; Mary Kuffel; Chad Walden; Holger Behrsing; Matthew M Ames
Journal: J Drug Metab Toxicol Date: 2016-05-08

Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer.